Status: Recruiting
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Phase 1/2, open-label study of ETX-636 in participants with advanced solid tumors
Participants needed: 233
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Ensem TherapeuticsUpdated: Jun 23, 2026Locations: 15
Eligibility criteria
Metastatic or locally advanced and unresectable solid tumor that has progressed... [+4]
Has history (within ≤2 years before screening) of a solid tumor or hematological... [+5]